AGGRASTAT Side Effects

6758928-3 | Hyperbilirubinaemia, Thrombocytopenia
on May 21, 2010 Male patient from ITALY , 62 years of age, was diagnosed with ischaemic heart disease prophylaxis and was treated with Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia, thrombocytopenia. Aggrastat dosage: 144 Microgram/kg/daily Intravenous (not Otherwise Specified). During the same period patient was treated with CILASTATIN SODIUM (View Cilastatin Sodium Review and Cilastatin Sodium Label ), AUGEMENT /00756801/ (View Augement /00756801/ Review and Augement /00756801/ Label ), CIPROFLOXACIN LACTATE (View Ciprofloxacin Lactate Review and Ciprofloxacin Lactate Label ), IMIPENEM (View Imipenem Review and Imipenem Label ), OMEPROZOLE (View Omeprozole Review and Omeprozole Label ).

6731003-X | Intra-abdominal Haematoma, Pain, Peritoneal Haemorrhage, Shock Haemorrhagic, Thrombosis In Device
Patient was taking Aggrastat (View Usage). Patient had the following side effects: intra-abdominal haematoma, pain (What is pain?), peritoneal haemorrhage, shock haemorrhagic, thrombosis in device on Apr 30, 2010 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with myocardial infarction and. Aggrastat dosage: (1 Dose/daily Intravenous (not Otherwise Specified)). During the same period patient was treated with LOVENOX ((10000 Iu/bid Subcutaneous)) (View Lovenox Review and Lovenox Label ), ASPIRIN LYSINE (KARDEGIN) ((1 Dose/daily Oral)) (View Aspirin Lysine (kardegin) Review and Aspirin Lysine (kardegin) Label ), PLAVIX ((75 Mg Qd Oral)) (View Plavix Review and Plavix Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

6215824-8 | Chest Pain, Chills, Petechiae, Platelet Count Decreased, Pyrexia, Tachycardia, Unevaluable Event
Adverse event was reported on May 21, 2009 by a Female patient taking Aggrastat (View Usage) (Dosage: Intravenous Drip, 1 Hour Until) . Location: LEBANON , 66 years of age, After Aggrastat was administered, patient had the following side effects: chest pain (What is chest pain?), chills, petechiae, platelet count decreased, pyrexia, tachycardia, unevaluable event. During the same period patient was treated with CORVASAL (View Corvasal Review and Corvasal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BUMEX (View Bumex Review and Bumex Label ), HEPARIN (View Heparin Review and Heparin Label ), SERETIDE (View Seretide Review and Seretide Label ). Patient was hospitalized.

6051167-3 | Acute Myocardial Infarction, Disease Recurrence, Haemorrhagic Diathesis, Renal Failure, Respiratory Failure, Thrombocytopenia
on Sep 24, 2008 Female patient from ESTONIA , 71 years of age, weighting 134.5 lb, was diagnosed with cardiovascular event prophylaxis and was treated with Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, disease recurrence, haemorrhagic diathesis, renal failure, respiratory failure, thrombocytopenia. Aggrastat dosage: 0.25 Mg/ml Intravenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.


5959528-5 | Acute Pulmonary Oedema, Anaemia, Gastrointestinal Angiodysplasia Haemorrhagic
on Nov 06, 2008 Female patient from FRANCE , 67 years of age, was diagnosed with myocardial infarction and was treated with Aggrastat (View Usage). Patient had the following side effects: acute pulmonary oedema, anaemia, gastrointestinal angiodysplasia haemorrhagic. Aggrastat dosage: (25 Mg Total Intravenous Bolus), (intravenous Drip).

5911573-1 | Acute Myocardial Infarction, Cardiac Failure, Haemorrhagic Diathesis, Renal Failure Acute, Respiratory Failure, Thrombocytopenia
Patient was taking Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: acute myocardial infarction, cardiac failure, haemorrhagic diathesis, renal failure acute, respiratory failure, thrombocytopenia on Sep 24, 2008 from HUNGARY Additional patient health information: Female patient , 71 years of age, weighting 134.5 lb, was diagnosed with cardiovascular event prophylaxis and. Aggrastat dosage: ((0.25 Mg/ml) Intravenous. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), CLEXANE (View Clexane Review and Clexane Label ). Patient was hospitalized.

5908406-6 | Nausea, Platelet Count Decreased
Adverse event was reported on Sep 16, 2008 by a Female patient taking Aggrastat (View Usage) (Dosage: Intravenous) was diagnosed with angina unstable and. Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), platelet count decreased. During the same period patient was treated with NITROGLYCERIN (Intravenous) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

5873370-5 | Infusion Site Haematoma, Post Procedural Fistula
on Aug 21, 2008 Male patient from ITALY , 36 years of age, was diagnosed with coronary angioplasty and was treated with Aggrastat (View Usage). Patient had the following side effects: infusion site haematoma, post procedural fistula. Aggrastat dosage: (dose Not Reported) Intravenous (not Otherwise Specified)). During the same period patient was treated with HEPARIN ((intravenous (not Otherwise Specified))) (View Heparin Review and Heparin Label ).

5765369-4 | Thrombocytopenia
on Jun 09, 2008 Male patient from GERMANY , 70 years of age, weighting 165.3 lb, was diagnosed with acute coronary syndrome and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: thrombocytopenia. Aggrastat dosage: 0,1 Mg/h Continuously Iv.

5635660-0 | Left Ventricular Failure
Patient was taking Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: left ventricular failure on Feb 05, 2008 from FRANCE Additional patient health information: Male patient , 82 years of age, was diagnosed with acute myocardial infarction and. Aggrastat dosage: Intravenous Bolus, Intravenous Drip. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN /0002701/ (View Aspirin /0002701/ Review and Aspirin /0002701/ Label ). Patient was hospitalized.

5626841-0 | Cardiac Failure, Thrombosis In Device
Adverse event was reported on Jan 30, 2008 by a Male patient taking Aggrastat (View Usage) (Dosage: 25 Mcg/kg, 0.15 Mcg/kg, Intravenous Bolus, Intravenous Drip) was diagnosed with acute myocardial infarction and. Location: FRANCE , 53 years of age, Patient had the following side effects: cardiac failure, thrombosis in device. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ). Patient was hospitalized.

5622065-1 | Angina Unstable, Rales, Syncope, Troponin T Increased
on Jan 28, 2008 Male patient from ITALY , 82 years of age, weighting 196.2 lb, was diagnosed with cardiac enzymes increased, electrocardiogram st segment depression and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: angina unstable, rales, syncope, troponin t increased. Aggrastat dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN LMW (View Heparin Lmw Review and Heparin Lmw Label ).

5622062-6 |
on Jan 29, 2008 Female patient from ITALY , 87 years of age, weighting 176.4 lb, was diagnosed with cardiac enzymes increased, electrocardiogram st segment elevation and was treated with Aggrastat (View Usage). . Aggrastat dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5613389-2 | Anoxic Encephalopathy, Cerebral Ischaemia, Disease Progression, Haemoptysis, Renal Failure
Patient was taking Aggrastat (View Usage). Patient had the following side effects: anoxic encephalopathy, cerebral ischaemia, disease progression, haemoptysis, renal failure on Jan 17, 2008 from BELGIUM Additional patient health information: Male patient , 70 years of age, was diagnosed with angina unstable and. Aggrastat dosage: (0.4 Mcg/kg, 0.05 Mcg/kg). During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INSULIN (View Insulin Review and Insulin Label ), HEPARIN LMW (View Heparin Lmw Review and Heparin Lmw Label ), BURINEX (View Burinex Review and Burinex Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized and became disabled.

5613388-0 | Cardiac Arrest, Cerebrovascular Accident
Adverse event was reported on Jan 17, 2008 by a Male patient taking Aggrastat (View Usage) (Dosage: (4 Mcg/kg, 0.1 Mcg/kg)) was diagnosed with angina unstable and. Location: BELGIUM , 80 years of age, After Aggrastat was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), cerebrovascular accident. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), HEPARIN LMW (View Heparin Lmw Review and Heparin Lmw Label ), ZOCOR (View Zocor Review and Zocor Label ), SELOKEN (View Seloken Review and Seloken Label ). Patient was hospitalized and became disabled.

5584624-4 |
on Dec 19, 2007 Male patient from BELGIUM , 70 years of age, was diagnosed with angina unstable and was treated with Aggrastat (View Usage). . Aggrastat dosage: Intravenous. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INSULIN (View Insulin Review and Insulin Label ).

5584617-7 |
on Dec 19, 2007 Male patient from BELGIUM , 80 years of age, was diagnosed with angina unstable and was treated with Aggrastat (View Usage). . Aggrastat dosage: Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5528573-6 | Cardiogenic Shock
Patient was taking Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: cardiogenic shock on Nov 12, 2007 from JORDAN Additional patient health information: Female patient , 55 years of age, was diagnosed with acute myocardial infarction, angina unstable and. Aggrastat dosage: (intravenous (not Otherwise Specified)). During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLEXANE (View Clexane Review and Clexane Label ).

5521888-7 |
Adverse event was reported on Nov 07, 2007 by a Male patient taking Aggrastat (View Usage) (Dosage: Intravenous) was diagnosed with cardiac enzymes increased and. Location: ITALY , 81 years of age, weighting 187.4 lb, . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN (View Heparin Review and Heparin Label ).

5504716-5 | Acute Coronary Syndrome
on Oct 23, 2007 Female patient from GERMANY , 70 years of age, was diagnosed with acute myocardial infarction and was treated with Aggrastat (View Usage). Patient had the following side effects: acute coronary syndrome. Aggrastat dosage: 7.5 Ml Total Intravenous Bolus, (intravenous Drip). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MOXIFLOXACIN HYDROCHLORIDE (View Moxifloxacin Hydrochloride Review and Moxifloxacin Hydrochloride Label ), DIURETICS (View Diuretics Review and Diuretics Label ). Patient was hospitalized.

5494549-0 | Ejection Fraction Decreased, Troponin T Increased
on Oct 15, 2007 Female patient from ITALY , 78 years of age, weighting 216.1 lb, was diagnosed with cardiac enzymes increased, electrocardiogram st segment depression and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: ejection fraction decreased, troponin t increased. Aggrastat dosage: Intravenous (not Otherwise Specified)). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN (View Heparin Review and Heparin Label ), INSULIN (View Insulin Review and Insulin Label ).

5487419-5 | Blood Glucose Increased, Coronary Artery Stenosis, White Blood Cell Count Increased
Patient was taking Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, coronary artery stenosis, white blood cell count increased on Oct 04, 2007 from ITALY Additional patient health information: Male patient , 71 years of age, was diagnosed with angina unstable, cardiac enzymes increased and. Aggrastat dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5484833-9 | Cardiac Arrest
Adverse event was reported on Sep 29, 2007 by a Female patient taking Aggrastat (View Usage) (Dosage: (x 1 Intravenous Drip)) was diagnosed with angina unstable, myocardial infarction and. Location: JORDAN , 58 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLEXANE (View Clexane Review and Clexane Label ), PLAVIX (View Plavix Review and Plavix Label ).

5480854-0 | Cardiac Procedure Complication, Myocardial Infarction, Post Procedural Complication
on Oct 01, 2007 Male patient from BELGIUM , 65 years of age, was diagnosed with angina unstable and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: cardiac procedure complication, myocardial infarction, post procedural complication. Aggrastat dosage: (intravenous (not Otherwise Specified). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5474497-2 | Cardio-respiratory Arrest
on Sep 18, 2007 Male patient from FRANCE , 80 years of age, was diagnosed with myocardial infarction and was treated with Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest. Aggrastat dosage: (intravenous Bolus), (intravenous Drip). During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZOCOR (View Zocor Review and Zocor Label ).

5474491-1 | Cardiogenic Shock, Electromechanical Dissociation, Gastrointestinal Haemorrhage, Ventricular Arrhythmia
Patient was taking Aggrastat (View Usage). Patient had the following side effects: cardiogenic shock, electromechanical dissociation, gastrointestinal haemorrhage, ventricular arrhythmia on Sep 18, 2007 from FRANCE Additional patient health information: Male patient , 86 years of age, was diagnosed with acute myocardial infarction and. Aggrastat dosage: (intravenous Bolus), (intravenous Drip). During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5466900-9 | Haemorrhage, Myocardial Infarction
Adverse event was reported on Sep 18, 2007 by a Male patient taking Aggrastat (View Usage) (Dosage: Intravenous) was diagnosed with acute myocardial infarction and. Location: PHILIPPINES , 69 years of age, After Aggrastat was administered, patient had the following side effects: haemorrhage, myocardial infarction. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

5460658-5 | Angina Unstable, Blood Pressure Systolic Increased, Bundle Branch Block Right, Coronary Artery Stenosis, Electrocardiogram St Segment Depression
on Sep 12, 2007 Female patient from ITALY , 88 years of age, weighting 198.4 lb, was diagnosed with cardiac enzymes increased and was treated with Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable, blood pressure systolic increased, bundle branch block right, coronary artery stenosis, electrocardiogram st segment depression. Aggrastat dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), METFORMIN (View Metformin Review and Metformin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5458186-6 |
on Sep 06, 2007 Female patient from ITALY , 88 years of age, weighting 198.4 lb, was diagnosed with cardiac enzymes increased and was treated with Aggrastat (View Usage). . Aggrastat dosage: Intravenous (not Othwerwise Specified)). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), METFORMIN (View Metformin Review and Metformin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5458185-4 | Angina Unstable, Cardiac Arrest, Coronary Artery Dissection, Myocardial Infarction
Patient was taking Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: angina unstable, cardiac arrest (What is cardiac arrest?), coronary artery dissection, myocardial infarction on Sep 09, 2007 from JORDAN Additional patient health information: Female patient , 75 years of age, was diagnosed with angina unstable, myocardial infarction and. Aggrastat dosage: Intravenous (not Otherwise Specified)). During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5457996-9 |
Adverse event was reported on Sep 06, 2007 by a Male patient taking Aggrastat (View Usage) (Dosage: Intravenous (not Otherwise Specified))) was diagnosed with acute myocardial infarction and. Location: PHILIPPINES , 69 years of age, . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

5453532-1 |
on Aug 30, 2007 Male patient from ITALY , 72 years of age, weighting 154.3 lb, was diagnosed with cardiac enzymes increased and was treated with Aggrastat (View Usage). . Aggrastat dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN (View Heparin Review and Heparin Label ), INSULIN (View Insulin Review and Insulin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TICLOPIDINE HYDROCHLORIDE (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ).

5450959-9 | Myocardial Infarction, Post Procedural Complication
on Sep 04, 2007 Male patient from BELGIUM , 52 years of age, was diagnosed with angina unstable and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: myocardial infarction, post procedural complication. Aggrastat dosage: Intravenous. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5442934-5 | Cardio-respiratory Arrest, Cardiogenic Shock
Patient was taking Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, cardiogenic shock on Aug 28, 2007 from LEBANON Additional patient health information: Female patient , 60 years of age, . Aggrastat dosage: (intravenous (not Otherwise Specified)). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

5442932-1 | Myocardial Infarction
Adverse event was reported on Aug 28, 2007 by a Female patient taking Aggrastat (View Usage) (Dosage: (intravenous (not Otherwise Specified))) was diagnosed with angina unstable and. Location: BELGIUM , 80 years of age, Patient had the following side effects: myocardial infarction. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN (View Heparin Review and Heparin Label ).

5433854-0 | Blood Creatine Phosphokinase Mb Increased, Cardiogenic Shock, Coronary Artery Stenosis, Ejection Fraction Decreased, Multi-organ Failure, Renal Failure Chronic, Septic Shock, Troponin T Increased
on Aug 15, 2007 Male patient from BELGIUM , 65 years of age, was diagnosed with angina unstable and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: blood creatine phosphokinase mb increased, cardiogenic shock, coronary artery stenosis, ejection fraction decreased, multi-organ failure, renal failure chronic, septic shock, troponin t increased. Aggrastat dosage: Intravenous Bolus, Intravenous Drip. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized and became disabled.

5424482-1 | Myocardial Ischaemia
on Aug 15, 2007 Female patient from BELGIUM , 80 years of age, was diagnosed with angina unstable and was treated with Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial ischaemia. Aggrastat dosage: Intravenous Bolus, Intravenous Drip. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), INSULIN (View Insulin Review and Insulin Label ), HEPARIN (View Heparin Review and Heparin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LASIX (View Lasix Review and Lasix Label ), LOSEC I.V. (View Losec I.v. Review and Losec I.v. Label ). Patient was hospitalized.

5421703-6 | Angina Pectoris, Blood Pressure Decreased, Haematoma, Haemoglobin Decreased, Haemorrhage, Left Ventricular Failure, Thrombocytopenia
Patient was taking Aggrastat (View Usage). Patient had the following side effects: angina pectoris, blood pressure decreased, haematoma, haemoglobin decreased, haemorrhage, left ventricular failure, thrombocytopenia on Aug 13, 2007 from GERMANY Additional patient health information: Male patient , 79 years of age, was diagnosed with acute myocardial infarction and. Aggrastat dosage: (144000 Mcg 1x/24 Hours 144,000 Mcg Daily Iv Intravenous). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5415508-X | C-reactive Protein Increased, Coronary Artery Stenosis, Electrocardiogram St Segment Depression, Myocardial Infarction, Post Procedural Complication
Adverse event was reported on Aug 06, 2007 by a Male patient taking Aggrastat (View Usage) (Dosage: Intravenous (not Otherwise Specified)) was diagnosed with angina unstable and. Location: BELGIUM , 65 years of age, After Aggrastat was administered, patient had the following side effects: c-reactive protein increased, coronary artery stenosis, electrocardiogram st segment depression, myocardial infarction, post procedural complication. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5415507-8 | Cardiogenic Shock
on Aug 06, 2007 Female patient from LEBANON , 60 years of age, was treated with Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock. Aggrastat dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

5394933-X | Ventricular Tachycardia
on Jul 16, 2007 Male patient from GERMANY , 75 years of age, was diagnosed with acute myocardial infarction and was treated with Aggrastat (View Usage). Patient had the following side effects: ventricular tachycardia. Aggrastat dosage: (4.5 Ml Total Intravenous Bolus), (8 Ml Total Intravenous Drip).

5394932-8 | Acute Myocardial Infarction, Thrombosis In Device, Ventricular Fibrillation
Patient was taking Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: acute myocardial infarction, thrombosis in device, ventricular fibrillation on Jul 16, 2007 from GERMANY Additional patient health information: Male patient , 56 years of age, was diagnosed with acute myocardial infarction and. Aggrastat dosage: (7.5 Mg Total Intravenous Bolus), (14.5 Ml Total Intravenous Drip).

5394931-6 | Haemoglobin Decreased, Haemothorax, Post Procedural Complication
Adverse event was reported on Jul 16, 2007 by a Male patient taking Aggrastat (View Usage) (Dosage: (7.5 Ml Total Intravenous Bolus), (14 Ml Total Maintenance Infusion Intravenous Drip)) was diagnosed with acute myocardial infarction and. Location: GERMANY , 69 years of age, Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, haemothorax, post procedural complication.

5391698-2 | Gastric Perforation
on Jul 12, 2007 Female patient from NETHERLANDS , 40 years of age, was diagnosed with electrocardiogram st segment elevation and was treated with Aggrastat (View Usage). Patient had the following side effects: gastric perforation. Aggrastat dosage: (7.5 Ml (stopped Prematurely) Intravenous (not Otherwise Specified). Patient was hospitalized.

5388704-8 | Gastric Perforation
on Jul 05, 2007 Female patient from NETHERLANDS , 40 years of age, was diagnosed with electrocardiogram st segment elevation and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: gastric perforation. Aggrastat dosage: (intravenous (not Otherwise Specified)). During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5388700-0 |
Patient was taking Aggrastat (View Usage). on Jul 09, 2007 from BELGIUM Additional patient health information: Female patient , 80 years of age, was diagnosed with angina unstable and. Aggrastat dosage: (intravenous (not Otherwise Specified)). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), INSULIN (View Insulin Review and Insulin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5388699-7 | Acute Coronary Syndrome, Brain Stem Infarction, Cerebral Haemorrhage, Glomerular Filtration Rate Decreased, Subdural Haematoma, Troponin I Increased
Adverse event was reported on Jul 09, 2007 by a Male patient taking Aggrastat (View Usage) (Dosage: (50 Mcg/ml For 1 Day Intravenous (not Otherwise Specified))) was diagnosed with acute coronary syndrome and. Location: UNITED KINGDOM , 85 years of age, Patient had the following side effects: acute coronary syndrome, brain stem infarction, cerebral haemorrhage, glomerular filtration rate decreased, subdural haematoma, troponin i increased. During the same period patient was treated with ASPIRIN ((75 Mg Qd Oral)) (View Aspirin Review and Aspirin Label ), ENOXAPARIN SODIUM (Subcutaneous) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CLOPIDOGREL BISULFATE ((75 Mg Qd Oral)) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ). Patient was hospitalized.

5385418-5 | Cerebrovascular Accident
on Jul 03, 2007 Male patient from NETHERLANDS , 57 years of age, weighting 198.4 lb, was diagnosed with acute myocardial infarction and was treated with Aggrastat (View Usage). After Aggrastat was administered, patient had the following side effects: cerebrovascular accident. Aggrastat dosage: (intravenous (not Otherwise Specified)). During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5376495-6 | Myocardial Infarction
on Jun 15, 2007 Male patient from ITALY , 85 years of age, weighting 160.9 lb, was diagnosed with cardiac enzymes increased, electrocardiogram st segment depression and was treated with Aggrastat (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Aggrastat dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), HEPARIN (View Heparin Review and Heparin Label ), INSULIN (View Insulin Review and Insulin Label ).

5374130-4 | Haemoglobin Decreased, Haemorrhage, Puncture Site Haemorrhage, Shock, Thrombocytopenia
Patient was taking Aggrastat (View Usage). Patient had the following side effects: haemoglobin decreased, haemorrhage, puncture site haemorrhage, shock, thrombocytopenia on Jun 25, 2007 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with acute coronary syndrome and. Aggrastat dosage: (for 30 Minutes For 0 Days Intravenous Bolus), (before Starting Coronary Angiography For 4 Hours Int. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.